Viatris Inc
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/303% below fair value
$19.63−0.25 (-1.26%)
Close on Nov 20, 2026Market cap $22.55BP/E –Yield 2.45%
Viatris Deferred Income Tax Assets, Net by Quarter
Deferred Income Tax Assets, Net ($M)
Viatris Deferred Income Tax Assets, Net: $1,173M in Q3 2026, up 17.4% from a year earlier.
Latest, Q3 2026
1,173
Period ended Sep 30, 2026
Change on a year earlier
+17.4%
999 in Q3 2025
History
25 quarters
Since Q4 2019
Sources
24
Documents cited below
Where the Q3 2026 figure comes from
Source: SEC Form 10-Q (2026-11-05) ↗
Reported in SEC Form 10-Q / 10-K (Income Taxes Footnote XBRL).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Deferred Income Tax Assets, Net ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 1,173 | +17.4% | SEC Form 10-Q (2026-11-05) ↗ |
| Q2 2026 | Jun 30, 2026 | 1,158 | +25.3% | SEC Form 10-Q (2026-08-06) ↗ |
| Q1 2026 | Mar 31, 2026 | 1,109 | +35.7% | SEC Form 10-Q (2026-05-07) ↗ |
| Q4 2025 | Dec 31, 2025 | 1,061 | +40.9% | SEC Form 10-Q (2026-11-05) ↗ |
| Q3 2025 | Sep 30, 2025 | 999 | +30.9% | SEC Form 10-Q (2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 924 | +34.9% | SEC Form 10-Q (2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 818 | +25.2% | SEC Form 10-Q (2025-05-08) ↗ |
| Q4 2024 | Dec 31, 2024 | 753 | +8.7% | SEC Form 10-K (2026-02-26) ↗ |
| Q3 2024 | Sep 30, 2024 | 763 | -18.0% | SEC Form 10-Q (2024-11-07) ↗ |
| Q2 2024 | Jun 30, 2024 | 685 | -29.1% | SEC Form 10-Q (2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 653 | -31.9% | SEC Form 10-Q (2024-05-09) ↗ |
| Q4 2023 | Dec 31, 2023 | 693 | -25.2% | SEC Form 10-K (2025-02-27) ↗ |
| Q3 2023 | Sep 30, 2023 | 930 | -15.7% | SEC Form 10-Q (2023-11-08) ↗ |
| Q2 2023 | Jun 30, 2023 | 966 | -22.3% | SEC Form 10-Q (2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 959 | -25.4% | SEC Form 10-Q (2023-05-08) ↗ |
| Q4 2022 | Dec 31, 2022 | 926 | -30.5% | SEC Form 10-K (2024-02-28) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,104 | -24.0% | SEC Form 10-Q (2022-11-07) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,243 | -43.1% | SEC Form 10-Q (2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 1,286 | -35.6% | SEC Form 10-Q (2022-05-09) ↗ |
| Q4 2021 | Dec 31, 2021 | 1,333 | -38.0% | SEC Form 10-K (2023-02-27) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,452 | – | SEC Form 10-Q (2021-11-08) ↗ |
| Q2 2021 | Jun 30, 2021 | 2,184 | – | SEC Form 10-Q (2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,997 | – | SEC Form 10-Q (2021-05-10) ↗ |
| Q4 2020 | Dec 31, 2020 | 2,148 | +205.5% | SEC Form 10-K (2022-02-28) ↗ |
| Q4 2019 | Dec 31, 2019 | 703 | – | SEC Form 10-K (2021-03-01) ↗ |
Breakdown
What makes up deferred Income Tax Assets, Net
- Deferred Income Tax Liabilities, Net776 · Q3 2026
- Deferred Tax Assets Valuation Allowance–
- Uncertain Tax Positions Noncurrent Liability302 · Q3 2026
- Unrecognized Tax Benefits (UTB) Ending Balance–
- UTB Additions — Current Year Tax Positions–
- UTB Reductions — Settlements with Taxing Authorities–
- UTB Reductions — Lapse of Statute of Limitations–
Cite this data
StockData. (2026). Viatris Deferred Income Tax Assets, Net ($M), quarterly Q4 2019–Q3 2026 [Data set]. Compiled from Viatris SEC filings and investor materials. https://stockdatahq.com/stocks/vtrs/kpis/dta-net
See every metric in the Viatris KPI table. Data updated Nov 16, 2026.
See a number that looks wrong?